Recombinant Human Flt-3 Ligand - 1mg

Flt-3 Ligand (FLT3L or FLT-3L) is a ligand of class III tyrosine kinase receptor (Flt3) that is mainly expressed on hematopoietic stem cells/progenitor cells. Flt-3 Ligand is related to early hematopoietic regulation. When used in combination with cytokines such as IL-3, IL-6, and SCF, Flt-3 Ligand can exhibit a strong proliferative effect on primitive hematopoietic stem/progenitor cells. In addition, Flt-3 Ligand enhances the expansion of GM-CSF, IL-4, and TNF-alpha-induced DC cells, and exerts anti-tumor effects by promoting the proliferation, differentiation, and maturation of DC cells, NK cells, and cytotoxic T cells (CTLs) in vivo. Recombinant Human Flt-3 Ligand is expressed by mammalian cells, and is produced with raw materials of pharmaceutical applicable level. The host protein residue, nucleic acid residue and common pathogens are strictly controlled, and the production and quality management procedures of the product comply with GMP regulations to ensure the traceability of the production process and all raw materials. https://swissmodel.expasy.org/repository/uniprot/P49771